Global advanced therapeutics pharmaceutical outsourcing Market
Pharmaceuticals

Unlocking the Future of the Advanced Therapeutics Pharmaceutical Outsourcing Market: Growth Rate, Key Trends, and Opportunities for 2025-2034

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

Analyzing the Growth Rate of the Advanced Therapeutics Pharmaceutical Outsourcing Market: What’s the Expected CAGR for the Next Decade?

The market size of advanced therapeutics pharmaceutical outsourcing has seen consistent growth throughout recent times. The market, which was valued at $8.07 billion in 2024, is projected to increase to $8.43 billion in 2025, with a compound annual growth rate (CAGR) of 4.5%. The augmentation during the historic period can be ascribed to factors such as the expansion in biopharmaceutical infrastructure, augmented regulatory conformity, heightened demands for cutting-edge drugs to manage chronic and fatal diseases, enhanced efficacy, and a rising demand for customized medication.

The market size for advanced therapeutic pharmaceutical outsourcing is anticipated to see a significant surge in the coming years, increasing to $10.27 billion by 2029 with a compound annual growth rate (CAGR) of 5.1%. This growth in the forecasted period can be linked to the rising adoption of cell and gene therapies, an increased concentration on mRNA therapies, the escalating demand for innovative treatments, the enhancement in efficiency and cost-savings offered by outsourcing partners, and collaborative innovation. Key trends predicted in the forecast period include technological progression, increased expert knowledge in advanced therapeutics, rapidly growing pipeline of innovative therapies, incorporation of the latest technologies, and swift developments in gene therapy, cell therapy, and mRNA technologies.

Which Drivers Are Expected to Have the Greatest Impact on the advanced therapeutics pharmaceutical outsourcing Market’s Growth?

The growth of the advanced therapeutics pharmaceutical outsourcing market is projected to be fueled by the rising use of cell and gene therapies. These innovative treatments utilize living cells or genetic matter to treat or cure diseases. Outsourcing in advanced therapeutics pharmaceuticals is employed in cell and gene therapies, giving companies access to proven providers and trained staff, which saves them the effort and resources of establishing their own teams. For instance, a Nature report from November 2023 indicated that the number of new patients receiving gene therapies is set to rise from 16,244 in 2020 to 94,696 in 2025. As such, the growing use of cell and gene therapies contributes to the expansion of the advanced therapeutics pharmaceutical outsourcing market.

Get Your Free Sample of the Global Advanced Therapeutics Pharmaceutical Outsourcing Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=13768&type=smp

What Are the Leading Organizations Impacting the Advanced Therapeutics Pharmaceutical Outsourcing Market’s Growth?

Major companies operating in the advanced therapeutics pharmaceutical outsourcing market report are:

• Thermo Fisher Scientific Inc._x000D_

• Laboratory Corporation of America Holdings_x000D_

• IQVIA_x000D_

• ICON plc_x000D_

• SGS SA_x000D_

What Are the Most Prominent Trends Driving Change in the Advanced Therapeutics Pharmaceutical Outsourcing Market?

Leading companies in the advanced therapeutics pharmaceutical outsourcing market are putting emphasis on strategic alliances to deliver trustworthy services to their clients. A strategic alliance is a cooperative agreement established amongst two or more entities, typically businesses, aimed at attaining shared benefits that each party could not obtain on their own. For example, in January 2023, Lonza, a Swiss enterprise specialising in manufacturing for the pharmaceutical, biotechnology, and nutrition industries, formed a partnership with Context Therapeutics Inc., an American biopharmaceutical corporation creating drugs for solid tumors. This collaboration entails Lonza conducting evaluations on manufacturability, gene and cell line construction, as well as process development for both the drug substance and product.

Get Instant Access to the Global Advanced Therapeutics Pharmaceutical Outsourcing Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/advanced-therapeutics-pharmaceutical-outsourcing-global-market-report

How Are the Key Segments of the Advanced Therapeutics Pharmaceutical Outsourcing Market Impacting Its Expansion and Revenue Streams?

The advanced therapeutics pharmaceutical outsourcing market covered in this report is segmented –

1) By Service Type: Contract Research Organizations (CROs), Contract Development And Manufacturing Organizations (CDMOs)

2) By Indication: Oncology, Neurology, Cardiology, Infectious Diseases, Other Indications

3) By Therapy: Cell Therapy, Gene Therapy, RNA-based Therapies

4) By Application: Preclinical Services, Clinical Services, Commercial Manufacturing And Packaging

Subsegments:

1) By Contract Research Organizations (CROs): Preclinical Research Services, Clinical Trial Management Services, Regulatory Affairs Services, Data Management And Biostatistics

2) By Contract Development And Manufacturing Organizations (CDMOs): Drug Development Services, Formulation Development, Analytical Testing Services, Commercial Manufacturing Services

What Regions Are Leading the Charge in the Advanced Therapeutics Pharmaceutical Outsourcing Market?

North America was the largest region in the advanced therapeutics pharmaceutical outsourcing market in 2024. The regions covered in the advanced therapeutics pharmaceutical outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Parameters Define the Advanced Therapeutics Pharmaceutical Outsourcing Market’s Scope?

Advanced Therapeutic Pharmaceutical Outsourcing refers to contracting out specialized pharmaceutical services related to advanced therapeutic products. These products often include advanced therapies such as cell and gene therapies, personalized medicines, biologics, and other novel treatments. They are used to obtain specialized expertise and capabilities in producing, testing, and developing advanced therapeutic products.

Browse Through More Similar Reports By The Business Research Company:

Advanced Distribution Management System Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/advanced-distribution-management-system-global-market-report

Advanced Process Control Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/advanced-process-control-global-market-report

Advanced Driver Assistance Systems (ADAS) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/advanced-driver-assistance-systems-adas-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: